BR9204984A - Composto,processo para a preparacao desse composto,medicamento,processo para a preparacao desse medicamento e aplicacao do mencionado composto - Google Patents

Composto,processo para a preparacao desse composto,medicamento,processo para a preparacao desse medicamento e aplicacao do mencionado composto

Info

Publication number
BR9204984A
BR9204984A BR9204984A BR9204984A BR9204984A BR 9204984 A BR9204984 A BR 9204984A BR 9204984 A BR9204984 A BR 9204984A BR 9204984 A BR9204984 A BR 9204984A BR 9204984 A BR9204984 A BR 9204984A
Authority
BR
Brazil
Prior art keywords
compound
preparation
medicine
hydrogen atom
chemical structure
Prior art date
Application number
BR9204984A
Other languages
English (en)
Portuguese (pt)
Inventor
Hans-Jochen Dr Lang
Christoph Dr Naumann
Denis Carniato
Anne-Maril Moura
Ryoichi Satoh
Masakazu Katoh
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9204984A publication Critical patent/BR9204984A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/405—Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9204984A 1991-12-12 1992-12-11 Composto,processo para a preparacao desse composto,medicamento,processo para a preparacao desse medicamento e aplicacao do mencionado composto BR9204984A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4140908 1991-12-12
DE4211976 1992-04-09

Publications (1)

Publication Number Publication Date
BR9204984A true BR9204984A (pt) 1993-06-15

Family

ID=25910001

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9204984A BR9204984A (pt) 1991-12-12 1992-12-11 Composto,processo para a preparacao desse composto,medicamento,processo para a preparacao desse medicamento e aplicacao do mencionado composto

Country Status (16)

Country Link
US (1) US5294608A (enExample)
EP (1) EP0546548B1 (enExample)
JP (1) JP3377234B2 (enExample)
KR (1) KR100269544B1 (enExample)
AT (1) ATE152453T1 (enExample)
AU (1) AU657018B2 (enExample)
BR (1) BR9204984A (enExample)
CA (1) CA2085171C (enExample)
DE (1) DE59208426D1 (enExample)
DK (1) DK0546548T3 (enExample)
ES (1) ES2101012T3 (enExample)
FI (1) FI105550B (enExample)
MX (1) MX9207215A (enExample)
NZ (1) NZ245414A (enExample)
RU (1) RU2124519C1 (enExample)
TW (1) TW222637B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
ES2129485T3 (es) * 1992-12-02 1999-06-16 Hoechst Ag Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
JPH06298779A (ja) * 1993-04-15 1994-10-25 Hoechst Japan Ltd ヘテロ環イミノビスメチレンビスホスホン酸誘導体
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE69819311T2 (de) * 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
WO1998039344A1 (en) * 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
WO2006039721A2 (en) * 2004-10-08 2006-04-13 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
EP2001486A4 (en) * 2006-03-17 2010-12-29 Univ Illinois BIPHOSPHONATE COMPOUNDS AND CORRESPONDING METHODS
US7457149B2 (en) 2006-05-05 2008-11-25 Macronix International Co., Ltd. Methods and apparatus for thermally assisted programming of a magnetic memory device
JP2010523709A (ja) * 2007-04-12 2010-07-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ Fpps、ggpps及びdppsを含む複数の標的に対して高い効能を有するビスホスホネート化合物及び方法
KR102956231B1 (ko) * 2023-10-12 2026-04-23 재단법인대구경북과학기술원 포스폰산 디페닐아민 화합물 및 이를 포함하는 페로브스카이트 태양전지

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US4812311A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0282309A3 (en) * 1987-03-11 1990-03-14 Yamanouchi Pharmaceutical Co. Ltd. Azole-aminomethylene bisphosphonic acid derivatives
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives

Also Published As

Publication number Publication date
FI925617A0 (fi) 1992-12-10
EP0546548A1 (de) 1993-06-16
DK0546548T3 (da) 1997-10-13
JPH05271260A (ja) 1993-10-19
DE59208426D1 (de) 1997-06-05
AU3017392A (en) 1993-06-17
CA2085171C (en) 2003-12-02
EP0546548B1 (de) 1997-05-02
NZ245414A (en) 1995-04-27
MX9207215A (es) 1993-06-01
FI105550B (fi) 2000-09-15
US5294608A (en) 1994-03-15
ATE152453T1 (de) 1997-05-15
RU2124519C1 (ru) 1999-01-10
CA2085171A1 (en) 1993-06-13
FI925617A7 (fi) 1993-06-13
TW222637B (enExample) 1994-04-21
KR100269544B1 (ko) 2000-10-16
ES2101012T3 (es) 1997-07-01
AU657018B2 (en) 1995-02-23
JP3377234B2 (ja) 2003-02-17

Similar Documents

Publication Publication Date Title
TW222637B (enExample)
HUP9800462A2 (hu) Aril-szulfonil-amino-hidroxámsav-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
FI913478A0 (fi) Diazinderivat.
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
ES8104993A1 (es) Un procedimiento para preparar compuestos aromaticos susti- tuidos
ATE186727T1 (de) Substituierte 3-arylidinene-7-azaoxindol verbindungen und verfahren zu ihrer herstellung
AR034268A1 (es) Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
ES2070175T3 (es) Derivados de acido 4-oxoquinolino-3-carboxilico, su preparacion y su uso.
DK0463560T3 (da) Nye antiepileptiske midler
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
TR199802253T2 (xx) Alkilaminobenzotiazol ve benzoksazol t�revleri
HUT56092A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions containing them
MX9200485A (es) Proceso para la obtencion de derivados de tetra hidro piridina y composicion farmaceutica que los contiene.
ES2054653T3 (es) Un procedimiento para preparar un compuesto quimico.
ES8507527A1 (es) Procedimiento para producir derivados de tiatriazina
NO864665D0 (no) Nye basisk substituerte pyridinforbindelser, fremgangsmaate til deres fremstilling, legemiddel inneholdende dem, og deres anvendelse.
HUT51618A (en) Process for producing substituted 3-amino-sydnonimine compounds and containing these ones pharmaceutical preparations
ES8604122A1 (es) Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas farmaceuticamente aceptables
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
ES2092822T3 (es) Procedimiento para la preparacion de derivados del acido bis(aminometil)fosfinico.
DK0853619T3 (da) Disubstituerede piperidinderivater
SE8701524D0 (sv) Nya sulfonamider och deras framstellningsforfarande
GB1065684A (en) Pseudo-oxatriazoles
ECSP993239A (es) Derivados de higromicina

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal